Press Releases
January 23rd 2012
Amarantus BioSciences Licenses Parkinson’s Disease Diagnostic Biomarker Test from Power3 Medical Products
Read more
January 20th 2012
Amarantus BioSciences Interview at the 2012 Biotech Showcase
Read more
January 12th 2012
Amarantus BioSciences to be Interviewed on The Big Biz Radio Show
Read more
January 11th 2012
Amarantus BioSciences Awarded US Patent Protecting Composition of Matter for MANF
Read more
January 9th 2012
NFL Veterans Corey Chavous and Jack Brewer Support Amarantus BioSciences’ Traumatic Brain Injury Research
Read more
January 3rd 2012
Amarantus BioSciences Updates Shareholders on Execution of Expanded Corporate Strategy
Read more
December 15th 2011
Amarantus BioSciences Appoints Mark J. Benedyk, PhD as Strategic Advisor
Read more
December 1st 2011
Amarantus BioSciences to Present at the National Investment Banking Association’s (NIBA) 120th Investment Conference
Read more
November 30th 2011
Amarantus BioSciences Receives Grant from Brewer Sports International for Traumatic Brain Injury
Read more
November 22nd 2011
Amarantus BioSciences and Banyan Biomarkers announce Traumatic Brain Injury Research Collaboration
Read more
November 15th 2011
Amarantus BioSciences’ Gerald and Dr. John Commissiong Selected as Black Money’s “50 Most Important African-Americans in Technology”
Read more
November 1st 2011
Amarantus BioSciences Expands Corporate Strategy
Read more
October 28th 2011
Amarantus BioSciences Appoints Gerald Commissiong President & CEO
Read more
October 25th 2011
Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor
Read more
October 20th 2011
Amarantus BioSciences Receives Notice of Allowance for U.S. Patent Covering MANF Discovery
Read more
October 13th 2011
Amarantus BioSciences Announces Close of $10M Equity Funding Facility with Centurion Private Equity, LLC
Read more
October 10th 2011
Amarantus BioSciences Announces Close of Convertible Bridge Note
Read more
September 21st 2011
Amarantus BioSciences Retains Danny Lee for Corporate Development
Read more
August 4th 2011
Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
Read more
August 2nd 2011
Amarantus BioSciences Presents Summary of Peer-Reviewed Data for Parkinson’s Program
Read more
July 26th 2011
Amarantus BioSciences Reports Positive Data in Parkinson’s Program
Read more
July 12th 2011
Amarantus BioSciences and Generex Biotechnology Announce
Collaboration to Treat Pre-Diabetes
Read more
June 14th 2011
Amarantus BioSciences Announces Completion of Capital Restructuring
Read more
June 8th 2011
Generex Biotechnology and Amarantus BioSciences Announce Oral-lyn-focused Collaboration Program
Read more
June 2nd 2011
Amarantus BioSciences Issues Overview of Development Strategies to Shareholders
Read more
May 31st 2011
Amarantus BioSciences Announces Partnership Agreement with Generex Biotechnology
Read more
July 27th 2010
Amarantus Therapeutics Obtains European Patent Notice of Allowance Covering Discovery of Lead Protein MANF
Read more
June 17th 2010
Amarantus Therapeutics Announces Appointment of Lawrence M. Schwartz, Ph.D., to Scientific Advisory Board Read more
May 24th 2010
Amarantus Therapeutics Appoints Dr. Robert J. Zimmerman as Chief Development Officer
Read more
April 27th 2010
Michael J. Fox Foundation for Parkinson’s Research Awards Grant To Amarantus Therapeutics
Read more
January 7th, 2010
Amarantus Therapeutics Inc. to Present at the OneMedForum 2010 Conference
Read More
December 17th, 2009
Amarantus Therapeutics Announces Key Additions to Scientific Advisory Board
Read More
October 28th, 2009
CNS Protein Therapeutics completes name change to Amarantus Therapeutics, appoints new CEO Martin D. Cleary
Read More
Newsletter
February 26th 2010
Amarantus releases Q1 2010 Newsletter Read more